About Moorfields Eye Hospital, NIHR Clinical Research Facility
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Moorfields Eye Hospital, NIHR Clinical Research Facility
During the past decade, Moorfields Eye Hospital, NIHR Clinical Research Facility conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
2005-11-01
2018-01-01
Completed
2,334
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
2007-06-01
2023-10-16
Active, not recruiting
1,501
Stress Management Therapy in Patients Receiving Chemotherapy for Cancer
2006-12-01
2010-05-01
Completed
442
Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
2008-02-25
Active, not recruiting
165
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
2007-12-06
Active, not recruiting
1,052
Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
2008-06-15
2015-05-28
Completed
210
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
2012-06-18
Unknown status
1,070
AtriCure Exclusion of the LAA in Patients Undergoing Concomitant Cardiac Surgery
2008-09-01
2011-10-01
Completed
70
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Moorfields Eye Hospital, NIHR Clinical Research Facility
According to Clinical.Site data, the most researched conditions in "Moorfields Eye Hospital, NIHR Clinical Research Facility" are
"Corneal Diseases" (1 trials), "Descemet's Membrane Disorder" (1 trials), "Endocrine System Diseases" (1 trials), "Exophthalmos" (1 trials) and "Eye Diseases" (1 trials). Many other conditions were trialed in "Moorfields Eye Hospital, NIHR Clinical Research Facility" in a lesser frequency.
Clinical Trials Intervention Types at Moorfields Eye Hospital, NIHR Clinical Research Facility
Most popular intervention types in "Moorfields Eye Hospital, NIHR Clinical Research Facility" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Linsitinib" (1 trials), "Placebo" (1 trials) and "QR-504a" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Moorfields Eye Hospital, NIHR Clinical Research Facility
The vast majority of trials in "Moorfields Eye Hospital, NIHR Clinical Research Facility" are
2 trials for "All" genders.
Clinical Trials Status at Moorfields Eye Hospital, NIHR Clinical Research Facility
Currently, there are NaN active trials in "Moorfields Eye Hospital, NIHR Clinical Research Facility".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Moorfields Eye Hospital, NIHR Clinical Research Facility,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Moorfields Eye Hospital, NIHR Clinical Research Facility, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".